Search for biomarkers of aggressiveness in bladder cancer

被引：10

作者：

Egawa, Shin ^{[1
]}

Kuruma, Hidetoshi ^{[1
]}

机构：

[1] Jikei Univ, Sch Med, Dept Urol, Minato Ku, Tokyo 1058461, Japan

来源：

EUROPEAN UROLOGY | 2006年 / 50卷 / 01期

关键词：

D O I：

10.1016/j.eururo.2006.01.059

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：20 / 22

页数：3

共 10 条

[1] Celis JE, 1996, CANCER RES, V56, P4782
[2] ACCUMULATION OF NUCLEAR P53 AND TUMOR PROGRESSION IN BLADDER-CANCER
ESRIG, D
ELMAJIAN, D
GROSHEN, S
FREEMAN, JA
STEIN, JP
CHEN, SC
NICHOLS, PW
SKINNER, DG
JONES, PA
COTE, RJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (19) : 1259 - 1264
[3] Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, γ-synuclein, and catechol-o-methyltransferase) identified by proteomic analysis
Iwaki, H
Kageyama, S
Isono, T
Wakabayashi, Y
Okada, Y
Yoshimura, K
Terai, A
Arai, Y
Iwamura, H
Kawakita, M
Yoshiki, T
[J]. CANCER SCIENCE, 2004, 95 (12): : 955 - 961
[4] High molecular mass proteome of androgen-independent prostate cancer
Kuruma, H
Egawa, S
Oh-Ishi, M
Kodera, Y
Satoh, M
Chen, WG
Okusa, H
Matsumoto, K
Maeda, T
Baba, S
[J]. PROTEOMICS, 2005, 5 (04) : 1097 - 1112
[5] Malats W, 2005, LANCET ONCOL, V6, P678
[6] Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas
Ohlsson, G
Moreira, JMA
Gromov, P
Sauter, G
Celis, JE
[J]. MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (04) : 570 - 581
[7] Gene discovery in bladder cancer progression using cDNA microarrays
Sanchez-Carbayo, M
Socci, ND
Lozano, JJ
Li, WT
Charytonowicz, E
Belbin, TJ
Prystowsky, MB
Ortiz, AR
Childs, G
Cordon-Cardo, C
[J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (02) : 505 - 516
[8] The predictive value of p53, p27Kip1, and α-catenin for progression in superficial bladder carcinoma
Schrier, Barthold Ph.
Vriesema, Jessica L. J.
Witjes, J. Alfred
Kiemeney, Lambertus A. L. M.
Schalken, Jack A.
[J]. EUROPEAN UROLOGY, 2006, 50 (01) : 76 - 82
[9] Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: Comparison with Cytokeratin 20
Wu, XX
Kakehi, Y
Zeng, Y
Taoka, R
Tsunemori, H
Inui, M
[J]. JOURNAL OF UROLOGY, 2005, 174 (06) : 2138 - 2142
[10] Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: Detection of circulating cancer cells in the peripheral blood of metastatic patients
Yuasa, T
Yoshiki, T
Isono, T
Tanaka, T
Hayashida, H
Okada, Y
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (06) : 286 - 292

← 1 →